Table 3.
Mean generic quality of life (SF-36), disease-specific quality of life (KCCQ), European heart failure self-care behaviour scale (EHFScBs), patient satisfaction (EUROPEP) and depression status (PHQ-9-D) scores for groups at baseline and seven-month follow-up
| Intervention group | Control group | No | ICC | |||||
| Score (SD) | No | Score (SD) | No | Adjusted mean difference** (95% CI); p***-value | ||||
| SF-36 scales* | ||||||||
| Physical functioning | Baseline | 52.2 (27.7) | 77 | 45.5 (27.8) | 64 | |||
| Seven months | 44.9 (28.9) | 77 | 43.6 (26.3) | 64 | 141 | 0 | -3.3 (-9.7 to 3.1); 0.30 | |
| Role functioning, physical | Baseline | 42.5 (44.4) | 67 | 34.3 (41.3) | 54 | |||
| Seven months | 31.3 (41.5) | 75 | 37.9 (43.5) | 60 | 119 | 0.12 | -5.9 (-19.7 to 7.8); 0.30 | |
| Bodily pain | Baseline | 63.2 (27.9) | 76 | 60.5 (29.5) | 64 | |||
| Seven months | 58.5 (29.9) | 76 | 53.8 (29.2) | 64 | 139 | 0.000 | 3.6 (-5.6 to 12.7); 0.43 | |
| General health perceptions | Baseline | 48.3 (17.8) | 77 | 44.2 (19.2) | 63 | |||
| Seven months | 44.9 (18.6) | 74 | 44.3 (18.2) | 64 | 137 | 0.000 | -2.0 (-7.5 to 3.6); 0.47 | |
| Vitality | Baseline | 43.9 (21.3) | 75 | 43.9 (22.5) | 63 | |||
| Seven months | 39.0 (21.3) | 77 | 43.1 (20.4) | 63 | 137 | 0.070 | -4.1 (-11.1 to 2.7); 0.22 | |
| Social functioning | Baseline | 75.3 (23.2) | 77 | 67.3 (27.4) | 63 | |||
| Seven months | 64.0 (31.4) | 77 | 64.8 (28.9) | 64 | 140 | 0.10 | -5.6 (-16.8 to 5.6); 0.31 | |
| Role functioning, emotional | Baseline | 65.9 (45.2) | 68 | 66.0 (46.0) | 54 | |||
| Seven months | 56.3 (47.0) | 71 | 60.3 (46.5) | 58 | 117 | 0.000 | -2.6 (-18.1 to 12.9); 0.73 | |
| Mental health | Baseline | 62.3 (20.2) | 75 | 66.0 (20.3) | 62 | |||
| Seven months | 58.9 (21.7) | 77 | 63.8 (20.0) | 63 | 136 | 0.002 | -1.8 (-8.0 to 4.4); 0.56 | |
| KCCQ* overall summary | ||||||||
| Baseline | 66.7 (20.9) | 78 | 63.6 (20.2) | 60 | -2.4 (-9.3 to 4.4); 0.47 | |||
| Seven months | 64.0 (23.7) | 78 | 65.3 (20.9) | 64 | ||||
| EHFScBs**** | ||||||||
| Baseline | 24.4 (7.8) | 90 | 23.8 (7.5) | 70 | 1.3 (-0.9 to 3.5); 0.24 | |||
| Seven months | 24.1 (7.9) | 76 | 23.6 (6.8) | 64 | ||||
| EUROPEP***** | ||||||||
| Baseline | 105.8 (9.3) | 90 | 106.2 (8.7) | 69 | -0.5 (-4.1 to 3.2); 0.80 | |||
| Seven months | 104.8 (10.4) | 77 | 104.5 (10.8) | 63 | ||||
| PHQ-9****** | ||||||||
| sum score | Baseline | 7.4 (5.6) | 91 | 7.4 (5.8) | 76 | |||
| Seven months | 8.6 (5.9) | 77 | 7.4 (5.4) | 63 | 0.8 (-0.7 to 2.3); 0.30 | |||
| adjusted odds ratio******* (95% CI); p***-value | ||||||||
| No. (%) of Major Depressive Syndromes | Baseline | 12 (15.6) | 77 | 7 (11.1) | 63 | |||
| Seven months | 14 (18.2) | 77 | 8 (12.7) | 63 | 1.5 (0.5 to 4.6); 0.48 | |||
*High scores imply better health.
**Based on analysis of covariance comparing results at seven-month follow-up.
***Adjusted for baseline score, ICC, New York Heart Association class, gender and age.
****Scores range from 12–60; low scores imply better self-care behaviour.
*****Scores range from 23–115; higher scores imply higher patient satisfaction regarding provided care.
******For details see methods section
*******According to generalised linear mixed effect models with a logit link using SAS proc glimmix to compare the number of outcomes between groups